Financial Daily from THE HINDU group of publications
Saturday, July 02, 2005

News
Features
Stocks
Port Info
Archives
Google

Subscription

Group Sites

CORPORATE RESULTS

PHARMACEUTICALS


Natco Pharma posts Rs 15.13 cr loss in Q4
NATCO Pharma Ltd (NPL) has suffered a major net loss in the quarter ended March 2005 and a significant fall in net profit for the fiscal. For the quarter under consideration, the company suffered a net loss of Rs 15.13 crore on a turnover of ... More

REAL ESTATE & CONSTRUCTION


SAAG-RR Infra's net profit doubles to Rs 58.89 lakh
SAAG-RR Infra Ltd has reported a net profit of Rs 58.89 lakh for the year 2004-05, more than double than its previous year's figure of Rs 27.45 lakh. The company's turnover also increased to Rs 15.92 crore (Rs 11.58 crore). Profit before tax ... More

NBFCS


Shriram group cos see jump in profits
FOUR companies of the Chennai-based Shriram group have reported over 30 per cent increase in net profits for the last year over the previous year. All the four are non-banking finance companies, but Shriram Investments Ltd and Shriram Transport ... More


Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
Pick a Winner Stock Market Contest

Top Stories
Coke's Indian operations to see an overhaul


Stake dilution for knowhow acquisition — Tata Tele in talks with SK Telecom

VSNL close to tying up S. Africa telecom deal — Completes acquisition of Tyco Global

Wheat prices: A calm before the storm?

Pak likely to buy Indian sugar

Govt working on special credit plan for SMEs

In Focus

BHEL Disinvestment
China's revaluation
Dabhol power regenerated
Tracking the rains
Sethusamudram Canal Project
India Inc's overseas acquisition
More

In Depth

Gender Justice
Simple Economics
Tax Talk
More


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line